The inspection closed with 13 observations, the company said in a filing on Thursday.
- The observations won’t disrupt supplies or impact existing revenues from operations of this facility
- Novel Labs is Lupin’s facility in Somerset, U.S.
To contact the reporter on this story:
To contact the editors responsible for this story:
Anto Antony
© 2022 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.